Prevalence of FXI gene mutations in women with menorrhagia.

Prevalence of FXI gene mutations in women with menorrhagia. - FXI gene mutations in women with menorrhagia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35784

Enrollment

Registered

2011-10-26

Start date

2011-12-02

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FXI gen mutations

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: For patients • Patients with regular heavy menstrual bleeding (=menorrhagia). • Age over 18 years. • Written informed consent.;For healthy volunteers • women with normal menstrual blood loss. • Age over 18 years. • Written informed consent.

Exclusion criteria

Exclusion criteria: For patients: • Patients with postmenopausal, irregular, postcoital and intermenstrual bleeding. • Patients with an intra-uterine device or hormonal treatment. • Patients with anticoagulant, antithrombotic therapy or use of non-steroidal anti-inflammatory drugs (NSAIDs). ;Exclusion criteria for healthy volunteers : • women with postmenopausal, irregular, postcoital and intermenstrual bleeding. • women with an intra-uterine device or hormonal treatment. • women with anticoagulant, antithrombotic therapy or use of non-steroidal anti-inflammatory drugs (NSAIDs).

Design outcomes

Primary

Measure	Time frame
The prevalence and frequency of FXI gene mutations in patients with menorrhagia and healthy volunteers.	—

Countries

Netherlands

Outcome results